He has successfully led the development of 15 approved drugs worldwide across various therapeutic areas over his more than 20-year career
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
Fortis will assume complete operational and financial control, allowing it to consolidate the hospital's performance within its network
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
The sudden subsequent decision to suspend IXCHIQ is based on updated VAERS data
The new lineup includes CereTom Elite, OmniTom Elite, OmniTom Elite PCD, and BodyTom 32/64
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
The company is bringing precision therapies for gynaecological cancers
The facility will be positioned as a Centre of Excellence for tertiary care services
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
Subscribe To Our Newsletter & Stay Updated
